/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
  2. 292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2
292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders · Oct 1, 2026

Stop perfecting your product and start selling. Biotech veteran John Bonham-Carter on fundraising, customer focus, and knowing when to let go.

Founders Mistake Product Perfection for Progress, Chasing 'Fool's Gold'

Many founders, particularly scientists, get trapped in a cycle of endlessly improving their product. Instead, they should sell the 'good enough' version to a customer who needs it now, generating revenue and co-developing the product with a real partner to avoid running out of money.

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2 thumbnail

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·3 days ago

Investors Bet on a Founder's Heartfelt Story, Not Just the Product or Team

Fundraising isn't just about presenting a solid business plan. Investors are backing the founder's personal commitment and resilience. A compelling, authentic story about *why* you are building this company is the most critical element for securing investment in a high-risk venture.

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2 thumbnail

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·3 days ago

Great Founders Know When to Replace Themselves for the Next Stage of Growth

A founder's skillset is often stage-specific. Recognizing your strengths (e.g., 0-to-1) and planning to step aside for a different leader when the company enters a new growth phase (e.g., 10-to-100) is a sign of mature leadership, not failure.

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2 thumbnail

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·3 days ago

Running a Startup is More Like Raising Kids Than Executing an MBA Playbook

The chaotic, multi-hat nature of a startup shouldn't be intimidating. It's like parenting: there's no perfect manual, and you learn by doing. Having the right attitude and resilience is more predictive of success than any theoretical business knowledge.

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2 thumbnail

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·3 days ago

Treat Investor Selection Like a Hiring Decision for a Long-Term Partner

Fundraising is a two-way street. Founders should prioritize bringing on investors they genuinely like and can work with collaboratively. An investor becomes a frequent partner, so personal chemistry and the quality of their advice are as important as the capital they provide.

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2 thumbnail

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·3 days ago

Startup Excellence Comes From Accepting Mediocrity in Non-Core Functions

In a small company, no one is perfect at wearing every hat. Instead of striving for perfection everywhere, leaders should accept 'good enough' in non-critical areas (e.g. bookkeeping) and focus the team's energy and resources on where they can be truly world-class.

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2 thumbnail

292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·3 days ago